GSK Plc Completes Acquisition Of Aiolos Bio finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GSK said on Thursday
it had completed the acquisition of Aiolos Bio, a clinical-stage
biopharmaceutical company focused on respiratory and
inflammatory conditions. GSK will pay $1.
GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions. GSK will pay $1 billion upfront and up to $400 million in success-based milestone payments. "In addition, GSK will also be responsible for success-based milestone payments as well as tiered royalties owed to Jiangsu Hengrui Pharmaceuticals Co, Ltd," the group said.